vimarsana.com

Page 10 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fisher Asset Management LLC Sells 70,706 Shares of Veracyte, Inc (NASDAQ:VCYT)

Fisher Asset Management LLC cut its holdings in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 3.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,014,898 shares of the biotechnology company’s stock after selling 70,706 shares during the quarter. Fisher Asset Management […]

Veracyte (NASDAQ:VCYT) Shares Up 6 4%

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report)’s stock price was up 6.4% during mid-day trading on Tuesday . The stock traded as high as $26.83 and last traded at $26.83. Approximately 395,949 shares were traded during trading, a decline of 42% from the average daily volume of 688,058 shares. The stock had previously closed at […]

Veracyte (NASDAQ:VCYT) Shares Up 6 4%

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) shares shot up 6.4% during trading on Tuesday . The company traded as high as $26.83 and last traded at $26.83. 395,949 shares traded hands during mid-day trading, a decline of 42% from the average session volume of 688,058 shares. The stock had previously closed at $25.21. Analyst […]

AMI Asset Management Corp Makes New Investment in Veracyte, Inc (NASDAQ:VCYT)

AMI Asset Management Corp acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund acquired 163,576 shares of the biotechnology company’s stock, valued at approximately $3,648,000. Several other large investors also recently bought and sold shares of the business. JPMorgan Chase & Co. […]

Veracyte, Inc (NASDAQ:VCYT) Receives $30 20 Consensus Target Price from Brokerages

Veracyte, Inc. (NASDAQ:VCYT – Free Report) has earned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.